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1. Abstract 
Purpose: The study was designed to assess correlations between intraoperative findings in 
revision tympanomastoidectomy as predictors of cholesteatoma recurrence. Materials and 
Methods:  A retrospective single-institution cohort of 101 patients who underwent surgical 
treatment for recurrent chronic otitis media in a tertiary referral otology center. Results: Out of 
101 patients, 65 had canal wall up and 36 canal wall down revision surgery. There were 35 
cholesteatoma recurrences. Sites most commonly associated with recurrent disease were residual 
facial ridge cells in 46 (45.5%), ossicular chain sites in 46 (45.5%) patients, posterior external 
auditory canal wall erosions in 38 (37.6%) patients and mastoid apex recurrence in 35 (34.7%) 
patients. Ossicular and posterior external auditory canal wall erosion and incomplete removal of 
mastoid apex cells correlate well with cholesteatoma recurrence accompanied by canal wall up 
surgery (p=0.009). Residual mastoid apex cells, posterior external auditory canal wall erosion 
and presence of residual facial ridge cells were identified as the strongest positive predictors of 
cholesteatoma recurrence, identifying high risk patients associated with canal wall down 
procedures. (p=0.0036) Conclusions: Correlations between intraoperative findings and 
cholesteatoma recurrence could improve preoperative and intraoperative planning and reduce the 
rates of postoperative failures1 due to mismanagement of high risk areas. 
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2. Introduction 
Chronic otitis media with cholesteatoma remains one of the most commonly surgically treated 
disorders in otology. Areas of recurrence after initial surgery can encompass disease limited to 
the tympanic cavity, but can also lead to extensive erosion of surrounding structures and 
temporal bone involvement. The main goals of revision surgery are to eliminate mucosal and 
bone disease while choosing the optimal surgical procedure plan. [1] Numerous published papers 
deal with two major surgical procedures that are used in achieving disease control: canal wall 
down (CWD) and canal wall up (CWU) procedures. Several factors have been described to 
contribute to postoperative failure after CWD surgery; small meatus, high facial ridge, dependent 
mastoid tip, granulation and poor cavity design. [2,3] Identifying and correcting residual disease 
factors converts discharging ears into dry, safe ears in most cases. However, few authors have 
investigated connections between intraoperative findings in revision surgery as predictors of 
cholesteatoma recurrence. Little literature is available in guiding the clinical decision making 
process in planning revision surgery. Improving preoperative and intraoperative understanding of 
recurrence patterns enables adequate control of the disease. The aim of this paper is to examine 
the intraoperative details of revision tympanomastoidectomy and analyze the patterns of 
cholesteatoma recurrence in the mastoid and tympanic cavity. It is our hypothesis that clinically 
useful patterns of cholesteatoma recurrence can be identified and that these patterns can help in 
deciding on the type of revision surgery. 
 
 
 
3. Materials and Methods     
This retrospective longitudinal cohort study and its protocol included 123 patients diagnosed 
with recurrent chronic otitis media and was approved by the University Hospital Centre 
Bioethical Board adhering to the Helsinki Declaration Revision of 1989. All patients who 
underwent canal wall up (CWU) or canal wall down (CWD) revision tympanomastoidectomy 
from January 1
st
, 2010 to December 31
st
, 2015 in our National Referral Centre for Otology were 
eligible for inclusion. The procedures were performed by an otologic team of 3 surgeons, with 
complete intraoperative notes obtained and analyzed. The patients were included consecutively, 
with demographic information, time and type of previous surgery, intraoperative anatomical and 
procedural details noted. All of the patients signed informed consent forms after evaluation by an 
otologist. Strict study protocol criteria excluded 22 patients due to incomplete documentation. 
Data for 12 sites of chronic otitis media with possible cholesteatoma recurrence were identified 
during revision surgery, documented by the same team of otologists. The large percentage of 
patients (80.3%) that had previous surgery at other institutions did not influence the quality of 
data obtained during the preparation of this manuscript. All of the patient’s previous records 
were available, and the data were collected from uniform sources and intraoperative notes from 
our institution, created through a uniform manner of writing. Statistical analysis was performed 
using MedCalc software (Version 11.2.1 © 1993-2010. MedCalc Software bvba Software, 
Broekstraat 52, 9030 Mariakerke, Belgium), using standard descriptive statistics and frequency 
tabulation as indicated. Associations between variables were assessed using the Kruskal-Wallis 
test, chi-squared test and logistic regression with odds ratios (OR) with confidence intervals (CI) 
to test statistically significant correlations. All tests of statistical significance were performed 
using a two-sided 5% type I error rate.  
4. Results 
Patients’ age ranged from 8 to 82 years with a mean value of 42.6 years. Of the total of 101 
patients enrolled in the study, 56 (55.4%) were male and 45 (44.6%) female. There were 72 
(71,3%) patients with only one previous surgery, and 29 (28.7%) patients with multiple previous 
surgeries, with an average of 2.5 surgeries per patient. The average time elapsed from previous 
surgery was 8 years. Of the 101 patients, 20 (19.8%) had been treated in our institution prior to 
revision surgery.  The types of previous surgeries were tympanoplasties in 49 (48.5%) patients, 
tympanoplasties with ossicular chain reconstruction in 13 (12,9%) patients and CWU 
tympanomastoidectomies in 39 (38.6%) patients. The types of revision procedures were CWU 
tympanomastoidectomies in 65 (64.4%) patients and CWD tympanomastoidectomies in 36 
(35.6%) patients. (Table 1) In the CWD revision procedure group, 7 patients underwent a 
previous CWU tympanomastoidectomy, while in 29 patients CWD surgery was performed 
outright due to extensive cholesteatoma recurrence. (Table 2) 
The most common area of recurrent disease and debris retention were the residual facial ridge 
cells in 46 (45.5%) of patients and the ossicular chain in 46 (45.5%) patients, followed by 
cholesteatoma related erosion of the posterior external auditory canal wall in 38 (37.6%) 
patients, mastoid apex and antrum recurrence in 35 (34.7%) and 30 (29.7%) patients, 
respectively. (Table 3) Cholesteatoma recurrence was identified in 35 (34.7%) patients. Based on 
previously published areas of common recurrence, the patients were divided into 5 groups: 1. 
non-specific or normal finding, 2. residual facial ridge cells and ossicular chain recurrence, 3. 
posterior external auditory canal wall erosion, 4. mastoid recurrence, 5. tympanic cavity and 
mastoid recurrence. A significant correlation was shown between ossicular chain, posterior 
external auditory canal erosions, tympanic/mastoid cholesteatoma and CWD 
tympanomastoidectomy (p=0.02, Kruskal-Wallis test). (Figure 1) Another positive correlation 
was shown between ossicular, posterior external auditory canal wall erosion, incomplete removal 
of tympanic/mastoid cells and increasing cholesteatoma recurrence (p=0.009, Kruskal-Wallis 
test). (Figure 2) Naturally, a positive correlation was noted between recurrent cholesteatoma and 
an increasing propensity toward CWD procedures (p=0.001, chi-squared test). A positive 
correlation was also found between rising age and recurrence (p=0.028, Kruskal-Wallis test). 
(Figure 3)  
Outcomes in the logistic regression model were defined as recurrence of cholesteatoma and need 
for CWD procedure. When intraoperative sites of suspected cholesteatoma recurrence were 
analyzed, mastoid apex cells (OR 4.65, CI 0.69-31.22), posterior external auditory canal wall 
erosion (OR 2.42, CI 0.76-7.67), mastoid erosion (OR 2.01, CI 0.4-10.4) and residual facial ridge 
cells (OR 1.54, CI 0.49-4.85) were identified as the strongest positive predictors of 
cholesteatoma recurrence. Negative predictors of cholesteatoma recurrence were found to be 
tympanic perforation (OR 0.34, CI 0.11-1.05), dura exposition (OR 0.35, CI 0.07-1.81) and 
hypotympanum inflammation (OR 0.44, CI 0.05-3.91) (p=0.040, logistic regression). (Table 4) 
After analyzing the same intraoperative sites for correlation with performing CWD surgery, 
mastoid apex cells (OR 10.55, CI 1.44-77.4), posterior external auditory canal wall erosion (OR 
4.3, CI 1.23-14.97) and mastoid erosion (OR 1.2, CI 0.23-6.4) were identified as positive 
predictors leading to CWD surgery. In contrast, tympanic perforation (OR 0.34, CI 0.1-1.1), 
chronic inflammation tissue in the attic (OR 0.65, CI 0.08-5.3) and antrum (OR 0.57, CI 0.12-
2.6) were shown to correlate positively with CWU surgery (p=0.0036, logistic regression). 
(Table 5) 
 
5. Discussion  
A successful CWD surgical procedure in chronic otitis media should result with a dry 
postoperative cavity, with reported general failure rates ranging from 6 to 45%, and 
cholesteatoma recurrence in 5-49% of patients. [1,4,5] Published studies list the high facial ridge 
and inadequate meatoplasty as major factors leading to failure and revision surgery. Surgical 
failure is more frequent in patients with more severe disease, with residual tegmental, apical and 
sinodural cells causing prolonged ear discharge after both CWU and CWD initial procedures. 
[6,7] Recommendations for recurrent disease management encourage removal of all cells that do 
not drain into the middle ear. [1,2,6,8] The philosophy in revision surgery presented in this study 
was to remove cholesteatoma, sequestration and areas of re-infection while preserving the 
posterior external auditory canal wall, provided it had not been removed during previous surgery. 
Patients were followed-up by otoendoscopy and computed tomography in regular intervals, and a 
revision operation was scheduled if the findings suggested possible cholesteatoma recurrence. In 
the CWD revision procedure group, 7 patients underwent a previous CWU 
tympanomastoidectomy, while in 29 patients CWD surgery was performed outright due to 
extensive cholesteatoma recurrence. This is a strategy that has been known to ensure adequate 
surgical management of recurrent otitis media with cholesteatoma. [2,3,4] The CWD technique 
includes exenteration of residual mastoid cells, especially in the sinodural angle, saucerization of 
the mastoid cavity, exposure of the attic, lowering the facial ridge and wide meatoplasty with 
partial cavity obliteration, resulting in a trouble-free cavity in 83-96% of cases. [5,9] The most 
common area of recurrent disease in our patient population were the residual perifacial cells in 
both CWU and CWD procedures. Other areas merit attention as well, especially ossicular chain, 
posterior external auditory canal wall erosions and residual mastoid apex cells. The most 
common areas of disease recurrence are similar in published literature, indicating that systematic 
surgical mismanagement is a significant factor behind many of the revision cases. That is 
particularly stressed in papers discussing the role of a high facial ridge that leads to facial recess, 
hypotympanum and caudal mastoid debris retention. [6,10] Using inside-out (subcortical) 
mastoidectomy or failure to address disease around the head of the malleus may also promote 
recurrence and granulation formation. [1] Staging the procedure may augment functional results, 
but the majority of our patients were not generally interested in multiple-stage surgery due to 
previous surgical failure, especially if the contralateral ear was not affected.  
Out of 101 revision cases, 35 (34.7%) had recurrent cholesteatoma. Some authors report that 
84.8% of all cholesteatomas found in initial surgeries are located in the epitympanum, and only 
8% of cholesteatomas found in revision tympanomastoidectomies are located in the mastoid, 
concluding that intraoperative surgical findings cannot predict the pattern of recurrence. [11] 
This might be due to the absence of paired patient data samples in large studies evaluating initial 
and revision surgery intraoperative details. However, intraoperative findings in revision 
tympanomastoidectomy can be valuable in planning the extent of surgery and evaluating possible 
areas of cholesteatoma recurrence. Surgical technique quality is often labeled as a major factor 
influencing postoperative outcome rather than type of surgery alone. [12] A high incidence of 
residual cholesteatoma disease may be caused by inadequate preoperative and intraoperative 
surgical planning and failure to explore vital areas of high risk for residual disease. That, in turn, 
leads to a higher percentage of CWD procedures in revision surgery. [1,4,13] Large studies on 
revision surgery have not established significant correlations between surgical failure and 
intraoperative findings. [13] There have been reports linking tympanic facial canal dehiscence 
and lateral semicircular canal fistulas as well as posterior auditory canal bony erosion and stapes 
destruction, advising care in approaching the facial nerve tympanic segment. [14,15,16,17] 
Ossicular chain erosion has been identified in 15-62% of patients with chronic otitis media 
without cholesteatoma, and a correlation with posterior tympanic perforation was shown. [18] 
Otoendoscopic techniques could potentially reduce the need for CWD procedures in revision 
surgery and offer excellent visual access to areas of frequent recurrence, but have not shown to 
decrease the overall cholesteatoma recurrence rate so far. [19] 
Our results show that grouping areas of common recurrence patterns helps to identify patients 
with high risk of cholesteatoma recurrence. Certain novel connections between areas of 
recurrence may serve as early indicators of recurrence and lead the surgeon to areas of 
cholesteatoma involvement that might otherwise be overlooked. (Figures 1 and 2) They also 
indicate that additional exploration of high risk areas is advisable, especially in older patients 
that have a significantly higher rate of mastoid recurrence. This is most likely due to increased 
disease duration and undergoing several previous surgeries in the mastoid. (Figure 3)  
Defining outcomes in revision surgery as cholesteatoma recurrence on one side and need for 
CWD procedures on the other enables a better appraisal of individual risk, since not every 
cholesteatoma recurrence requires a CWD procedure. Logistic regression models identified 
residual mastoid apex cells, posterior external auditory canal wall erosion, mastoid erosion and 
residual cells along the facial ridge as the most reliable predictors of cholesteatoma recurrence. 
All of these areas need examining for possible disease when noting any one of them is involved. 
This is a clinically useful finding that has not been reported before with statistical significance. 
(Table 3) In addition, the same predictors were found to correlate very well with a higher 
propensity toward CWD surgery. The logistic regression model also identified tympanic 
perforation, chronic inflammation tissue in the attic and mastoid antrum as negative predictors 
for CWD surgery. These factors correlate with cholesteatoma recurrence limited to the tympanic 
cavity, requiring a less radical procedure. [20] (Table 4) Similar results have not been previously 
reported, and this study offers novel data on clinically useful patterns of cholesteatoma 
recurrence that may affect intraoperative decisions. The absence of available data supporting 
clinical decision making is often stressed, making novel data and risk stratification and 
prediction models of vital importance in planning and performing revision surgery. 
 
6. Conclusion 
In revision chronic otitis media surgery, expert clinical judgment and technical ability of the 
surgeon are important, augmented by intraoperative planning using novel data on high risk areas. 
Using patterns of cholesteatoma recurrence may lead to increased control of the disease in 
revision surgery. In addition, understanding the correlations between sites of recurrence can be 
helpful in deciding on the type of revision surgery. 
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Tables and Legends 
Table 1. Distribution of previous surgical procedures. 
  
Previous procedures   
Tympanoplasty 49 (48.5)  
Tympanoplasty with ossicular chain reconstruction 13 (12.9)  
Canal wall up tympanomastoidectomy 39 (38.6)  
Total 101  
   
 
 
 
 
 
 
 
 
 
 
Table 2. Distribution of revision tympanomastoidectomies with cholesteatoma recurrences 
observed during revision surgery. 
 
 N of patients 
(%) 
N of cholesteatoma 
recurrences noted during 
revision surgery (%) 
Revision procedures   
Canal wall up tympanomastoidectomy 65 (64.4) 6 (17.1) 
Canal wall down tympanomastoidectomy 36 (35.6) 29 (82.9) 
Total 101 35 
 
 
 
 
 
 
 
 
 
 
 Table 3. Distribution of intraoperative findings from 12 intraoperatively noted sites related to 
disease recurrence in CWD and CWU revision tympanomastoidectomies. 
 
Intraoperative finding CWU (N=65) 
(%) 
CWD (N=36) 
(%) 
Total (N=101) 
(%) 
Tympanic perforation 39 (60) 10 (27.8) 49 (48.5) 
Residual perifacial cells 24 (36.9) 22 (61.1) 46 (45.5) 
Ossicular chain erosion 31 (47.7) 15 (41.7) 46 (45.5) 
Posterior external auditory canal wall 
erosion 
20 (30.8) 18 (50) 38 (37.6) 
Residual mastoid apex cells  17 (26.2) 18 (50) 35 (34.7) 
Antrum inflammation 18 (27.7) 12 (33.3) 30 (29.7) 
Attic inflammation 16 (24.6) 10 (27.8) 26 (25.7) 
Dehiscent facial nerve canal 12 (18.5) 13 (36.1) 25 (24.8) 
Mastoid erosion and residual cells 11 (16.9) 12 (33.3) 23 (22.8) 
Residual sinodural angle cells 12 (18.5) 9 (25) 21 (20.8) 
Hypotympanum inflammation 10 (15.4) 6 (16.7) 16 (15.8) 
Dura exposition 8 (12.3) 8 (22.2) 16 (15.8) 
 
 
 
Table 4. Intraoperative findings as predictors of cholesteatoma recurrence in revision 
tympanomastoidectomy. 
 Odds ratio 
(confidence interval) 
Significance 
(p value) 
Positive predictors of outcome  
 
 
 
p=0.040, logistic 
regression 
Residual mastoid apex cells  4.65 (0.69-31.22) 
Posterior external auditory canal wall 
erosion 
2.42 (0.76-7.67) 
Mastoid erosion and residual cells 2.01 (0.4-10.4) 
Residual facial ridge cells 1.54 (0.49-4.85) 
 
Negative predictors of outcome 
Tympanic perforation 0.34 (0.11-1.05) 
Dura exposition 0.35 (0.07-1.81) 
Hypotympanum inflammation 0.44 (0.05-3.91) 
 
 
 
 
 
 
Table 5. Intraoperative findings as predictors of need for performing a CWD procedure in 
revision tympanomastoidectomy. 
 Odds ratio 
(confidence interval) 
Significance  
(p value) 
Positive predictors of outcome  
 
 
p=0.0036, logistic 
regression 
Residual mastoid apex cells  10.55 (1.44-77.4) 
Posterior external auditory canal wall 
erosion 
4.3 (1.23-14.97) 
Mastoid erosion and residual cells 1.2 (0.23-6.4) 
 
Negative predictors of outcome  
Tympanic perforation 0.34 (0.1-1.1) 
Attic inflammation 0.65 (0.08-5.3) 
Antrum inflammation  0.57 (0.12-2.6) 
 
 
 
 
 
 
 
 
Figure Legends 
 
 
Figure 1. Positive correlation between ossicular chain and posterior external auditory canal 
erosions, tympanic and mastoid chronic otitis findings and CWD tympanomastoidectomy 
(p=0.02, Kruskal-Wallis test). (1 - non-specific or normal finding, 2 - residual facial ridge cells 
recurrence, 3 - ossicular and posterior external auditory canal wall erosion, 4 - mastoid 
recurrence, 5 - tympanic cavity and mastoid recurrence) 
 
 
 
 Figure 2. Positive correlation between cholesteatoma recurrence and incomplete removal of 
tympanic cavity and mastoid cells (p= 0.009, Kruskal-Wallis test). (CHOL – cholesteatoma, 
COM – chronic otitis media findings, 1 - non-specific or normal finding, 2 - residual facial ridge 
cell recurrence, 3 - ossicular and posterior external auditory canal wall erosion, 4 - mastoid 
recurrence, 5 - tympanic cavity and mastoid recurrence) 
 
 Figure 3. Positive correlation between rising age (in years) and disease recurrence in the mastoid 
(p= 0.028, Kruskal-Wallis test). (1 - non-specific or normal finding, 2 - residual facial ridge cell 
recurrence, 3 - ossicular and posterior external auditory canal wall erosion, 4 - mastoid 
recurrence, 5 - tympanic cavity and mastoid recurrence) 
